Best Genomics Companies in Toronto, Canada
The 54 best Genomics companies in Toronto, Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Geneseeq.
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Toronto
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Geneseeq Providing personalised cancer treatment solutions based on patients genomic profile 55Talent top 28%Funding top 31%Moat top 40%Market bottom 49% All 5 signals ▾Talenttop 28% Fundingtop 31% Moattop 40% Marketbottom 49% Globalbottom 45% Talent: 4 named leaders on record · 4 C-suite/founder profiles curated Funding: Raised $128M across 3 rounds · 3 rounds over 12 yrs (0.2/yr) rank vs industry peers · Fliar Intelligence Index 55/100 | $128M | 78 mo ago | Series D | Xiaonan Wang Co-Founder & CTO | 2012 | — | — | — |
| 2 | Xagenic Provider of point-of-care molecular diagnostics for infectious diseases | $59M | 132 mo ago | Series C | — | 2010 | — | 50 patents Electrochemical biosensor platforms and precision current‑mode DACs for point‑of‑care diagnostics | — |
| 3 | iVexSol Developer of a platform for the production of vectors | $39M | 41 mo ago | Series A | Rodney Rietze Co-Founder & CEO | 2018 | — | — | — |
| 4 | Fio Point-of-care digital diagnostic integrated with cloud information services for infectious diseases | $11M | 115 mo ago | Series B | Michael Greenberg Chairman and Chief Executive Officer | 2006 | Cart FunctionalitySquarespace CommerceSquarespace+23 | 190 patents Point‑of‑care rapid immunoassay diagnostics with biomarker analytics and cloud data integration | — |
| 5 | DoseBiome Provider of prebiotic and probiotic products | $4M | — | Deadpooled | Ted Jin Founder & CEO | 2016 | — | — | — |
| 6 | Ranomics Database of rare genetic variants | $1M | 118 mo ago | Seed | — | 2015 | WixSentryBootstrap+17 | 7 patents High-throughput multisite saturation mutagenesis and splice‑junction variant analysis for gene engineering | — |
| 7 | Spindle Biotech Providers of tools for gene editing research | $250K | 85 mo ago | Acqui-Hired | Aaron Chung CEO | 2016 | — | 6 patents In vitro RNA synthesis reagents and methods for producing synthetic RNA molecules | — |
| 8 | Amino Provider of lab equipment for bacterial transformations and culture growth | $250K | 129 mo ago | Seed | — | 2015 | Cart FunctionalityShopifySentry+32 | — | — |
| 9 | Advanced Chemistry Development Labs Cheminformatics system | $245K | 62 mo ago | Acquired | — | 1994 | Cart FunctionalityWooCommerceWordPress+34 | — | 1 launch |
Top 12 Genomics companies in Toronto
#1
Series A · Toronto, Ontario · founded 2018 · 34 employees$39Mraised▾
iVexSol is a manufacturer and developer of the vector. It offers its flagship intelligent transformative platform for developing lentiviral vector cell lines.
- Jan 2023Series A$23.8M
- Dec 2020Series A$13M
- Aug 2020Seed$250K
- Sep 2019Seed$2M
#2
Series D · Toronto, Ontario · founded 2012$128.4Mraised▾
Geneseeq is a health solutions company that specializes in personalized cancer care and provides treatment solutions based on the comprehensive analyses of patients’ genomic profile (RNA) using NGS techniques primarily has developed customized RNA extraction protocols for all kinds of patient sample materials, including surgical sections, core needle biopsies, FFPE samples, and ultra-low input samples.
- Dec 2019Series D$114.4M
- Jul 2017Series C—
- Jun 2016Series B$9.4M
- Aug 2014Series A$4.7M
#3
Series C · Toronto, Ontario · founded 2010 · 45 employees$59.1Mraised▾
Xagenic is developing a point-of-care platform for decentralized, rapid molecular diagnostic testing. The Xagenic X1 technology platform permits the rapid, enzyme-free detection of nucleic acids from clinical samples with automated proprietary Xagenic AuRA cartridges. The procedure involves the patient's clinical specimen to be introduced into the cartridge using a proprietary specimen collection kit and tube that snaps into the cartridge. Then, after the insertion of the cartridge into the Xagenic X1 instrument, all processes are fully automated. It is also developing assays for infectious diseases to be used with their platform.
- Jul 2015Series C$11.8M
- Jul 2014Series B$25.5M
- Dec 2013Series A$9.6M
- Jan 2012Series A$10M
#4
Series B · Toronto, Ontario · founded 2006 · 40 employees$10.7Mraised▾
Point-of-care digital diagnostic integrated with cloud information services for infectious diseases. The company has developed a portable point-of-care device capable of molecular diagnosis of multiple infectious diseases from a small biological sample. Their product, Fionet, provides a point-of-care diagnosis for infectious disease. It works with mobile devices which automatically transmits primary data to a central web portal.
- Dec 2016Series B$8.3M
- Oct 2015Series A$75.7K
- Nov 2014Series A$100K
- Oct 2014Series A$704.8K
#5
Deadpooled · Toronto, Ontario · founded 2016 · 9 employees$4.3Mraised▾
DoseBiome is focused on oral microbiome research that improves the microbial ecosystem in the mouth by preventing diseases such as dental caries and periodontal conditions. The company is developing pre/probiotic consumer products that selectively reduce bad bacteria while promoting healthy populations of the good.
- Series A$4.3M
#6
Seed · Toronto, Ontario · founded 2015 · 6 employees$1.3Mraised▾
Ranomics is building a database of rare genetic variants. It uses a wet lab experimental pipeline to map all genetic variants and catalogs the functionality of each variant using data modeling and statistical analysis, which can then be accessed from a secure database. Currently, it has mapped all variants of the BRCA gene and is completing it for three more genes: TP53, CHEK2, and CDK4.
- Sep 2016Seed$1.2M
- Feb 2015Seed$100K
#7
Acquired · Toronto, Ontario · founded 1994 · 183 employees$245.3Kraised▾
Advanced Chemistry Development (ACD/Labs) is a cheminformatics company providing solutions in support of R&D. Its product portfolio includes Spectrus platform (spectral and chromatographic data handling, chemical handling, and nomenclature, unified laboratory intelligence), percepta platform (absorption, distribution, metabolism, and excretion (ADME); and toxicity tools in one seamless environment), and data management and informatics. In addition, it offers data management services.
- May 2021Grant (prize money)$128.5K
- Mar 2020Grant (prize money)$116.8K
#8
Acqui-Hired · Toronto, Ontario · founded 2016 · 2 employees$250Kraised▾
Spindle Biotech is the provider of tools for gene editing research. They use synthetic RNA instead of plasmid DNA. Synthetic RNA can minimize off-target activity by existing for only a defined amount of time before it naturally degrades, CRISPR research employs high throughput methods like phenotypic screening, requiring targets.
- 2019Seed$250K
#9
Seed · Toronto, Ontario · founded 2015 · 6 employees$250Kraised▾
Provider of lab equipment for bacterial transformations and culture growth. Its lab equipment Amino One is a laptop-sized personal bioreactor and transformation station that allows users to produce different cultures based on different kinds of cells engineered with recombinant DNA. The equipment also contains amino cell kits that use simple lab strains of yeast or E. coli and provides the DNA. It is also connected with wi-fi to view the experiments in real-time and generate reports.
- Oct 2015Seed$250K
#10
Series A · Toronto, Ontario · founded 2014 · 30 employees$35Kraised▾
DNAstack provides cloud-based solutions to store, manage and analyze genomics and relevant patient data. Its technology is based on DNA sequencing that has enabled the reading of individual genomes, creating the potential to improve diagnostics and treatment for patients affected by genetic diseases. It is part of a Canadian-led initiative to accelerate genomic data sharing worldwide and claims to have launched the largest known search engine for genetic mutations. It is supported by the Government of Ontario and FedDev Ontario through OCE’s Smartstart seed fund.
- Jan 2019Series A—
- Aug 2017Seed—
- Jun 2014Seed$35K
#11
Acquired · Toronto, Ontario · founded 2017 · 5 employees$20Kraised▾
Digital assistant offering genetic code-based health and fitness guidance. The platform offers DNA tests kits for genetic analysis. Based on the genetic results and analysis the app provides personalized wellness plans which include nutrition, exercise, sleep, and habits.
- 2020Seed$20K
- Sep 2018Seed—
#12
Seed · Toronto, Ontario · founded 2017 · 8 employees—raised▾
Provider of gene editing technologies to treat diseases at the genetic level. The company offers its proprietary technology for treating many genetic rare diseases and offers its gene-editing platform for cells inside the body by dual-cleaving nuclease that can be delivered to cells for treating many genetic diseases and DNA repair pathways and deletions. The company's many products like SB1-001, SB1-001, and others are in pipeline and the developmental stage.
- Mar 2026Grant (prize money)—
- Oct 2023Seed—
- Dec 2021Seed—
- Dec 2021Grant (prize money)—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Toronto is moving
A read on the academic research around Bioinformatics in Toronto — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 166 papers.
University of Toronto and affiliates lead Toronto's predominantly optimistic bioinformatics research, focusing on single-cell transcriptomics and cancer genomics, with recent output surging but concern papers tempering the tone.
- University of Toronto155
- Toronto General Hospital6
- Toronto Metropolitan University4
- Toronto Western Hospital2
- Toronto Public Health2
- Gene2→6
- Genome2→4
- Disease9
- Biomarker5
- Identification (biology)5
- Gut flora4
- Microbiome4
- Genome1→4
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.